Biomedical funder agrees it needs to do more to ensure its research includes neglected groups
Clinical trials funded by the US National Institutes of Health “often fell short” on including traditionally underrepresented groups among their participants, an analysis by a watchdog has found.
The Office of the Inspector General of the Department of Health and Human Services carried out the analysis and published its findings on 22 May.